2X Match My Gift
This National Cancer Survivors Month, your gift is matched to expand treatment options and bring more patients into survivorship through Project Cure CRC.

Colorectal cancer is the second deadliest cancer in the United States among men and women. Yet is also one of the few cancers that is preventable. Thanks to the work of researchers all over the world, fewer people are being diagnosed with colorectal cancer. However, we still have a long way to go. The Colorectal Cancer Alliance Chris4Life Research Program awards grants to researchers studying what motivates people to get screened earlier and detect or prevent this unique cancer.
Progress reports, publications, presentations, and more based on our recent work in colorectal cancer research.
This report documents the purpose, participants, and process underlying the 2021 research investment strategy planning and the strategic focus areas that developed therefrom.
This meeting report summarizes the 2021 State of the Science Summit event. The results from the summit, along with other inputs, will be used to inform scientific objectives and key funding strategies for the Alliance to establish the largest return on a $30 million research investment over the next 5 years.
Click on a research focus to see how we're using our research funds to accelerate treatment, prevention, and a cure.

Colorectal cancer is rising in people under 50, and no one knows why. We invest in research that aims to understand more about colorectal cancer in young people and how to prevent it.

Colorectal cancer rates vary among racial groups, age, and socioeconomic status. We support research that helps us understand why and how to improve early detection and treatment among diverse populations.

Nearly 50,000 people with be diagnosed with rectal cancer this year. We awards grants to encourage research in rectal cancer and to establish a successful career path in this field.

Colorectal cancer is one of the few cancers that is preventable. We support researchers studying what motivates people to get screened earlier and detect or prevent this unique cancer.

More survivors are beating colorectal cancer than ever before. However, we still have a long way to go. We need breakthroughs for advanced colorectal cancer and less toxic and more effective cancer treatments.

There is a tremendous unmet need for advancements in screening, treating, and caring for people with colorectal cancer. To foster innovation, we support the training of colorectal cancer researchers.
Help make lifesaving research possible. Your gift will be earmarked for the Colorectal Cancer Alliance Chris4Life Research Program.

A first-of-its-kind trial platform in the colorectal cancer space, Project Cure CRC’s KLEOS is being driven by the Colorectal Cancer Alliance, the leading nonprofit dedicated to ending the disease, in collaboration with GCAR, a pioneer in the design and implementation of innovative clinical trials.

The Colorectal Cancer Alliance is urging Americans to prioritize colorectal cancer screening, as the American Cancer Society (ACS) released updated guidelines today.

The Colorectal Cancer Alliance will present three poster sessions and deliver an oral presentation at the American Association for Cancer Research Annual Meeting 2026.